These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8452657)

  • 61. Sudden enlargement of the prostate in a patient taking Fansidar for malaria.
    Ajuonuma BC; Ajuonuma MU; Uzo-Ngerem A; Ajuonuma MK; Ajuonuma FO; Chukwu CL; Ajonuma LC
    Drug Metabol Drug Interact; 2007; 22(4):285-7. PubMed ID: 18447004
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
    Rombo L; Angel VH; Friman G; Hellgren U; Mittelholzer ML; Stürchler D
    Trop Med Parasitol; 1993 Sep; 44(3):254-6. PubMed ID: 8256106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
    Ugburo AO; Temiye EO; Ilombu CA
    Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
    Teira R; Virosta M; Muñoz J; Zubero Z; Santamaría JM
    Scand J Infect Dis; 1997; 29(6):595-6. PubMed ID: 9580544
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Guillain-Barré syndrome associated with Fansidar intake].
    Lorentzon B
    Lakartidningen; 1984 Aug; 81(34):2919. PubMed ID: 6471983
    [No Abstract]   [Full Text] [Related]  

  • 67. Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine.
    Feikin DR; Dowell SF; Nwanyanwu OC; Klugman KP; Kazembe PN; Barat LM; Graf C; Bloland PB; Ziba C; Huebner RE; Schwartz B
    J Infect Dis; 2000 Apr; 181(4):1501-5. PubMed ID: 10762585
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes.
    Abou-Eisha A; Afifi M
    Cell Biol Toxicol; 2004 Sep; 20(5):303-11. PubMed ID: 15685933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Adam I; A-Elbasit IE; Idris SM; Malik EM; Elbashir MI
    Ann Trop Med Parasitol; 2005 Jul; 99(5):449-55. PubMed ID: 16004704
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
    Foot AB; Garin YJ; Ribaud P; Devergie A; Derouin F; Gluckman E
    Bone Marrow Transplant; 1994 Aug; 14(2):241-5. PubMed ID: 7994239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271
    [No Abstract]   [Full Text] [Related]  

  • 73. [An unusual hemorrhagic variant of Stevens-Johnson syndrome in an HIV-infected patient].
    Schmid MH; Elsner P
    Hautarzt; 1999 Jan; 50(1):52-5. PubMed ID: 10068933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Boxed warning added to Fansidar labeling.
    FDA Drug Bull; 1985 Aug; 15(2):21. PubMed ID: 4054454
    [No Abstract]   [Full Text] [Related]  

  • 76. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
    Sarikabhuti B; Keschamrus N; Noeypatimanond S; Weidekamm E; Leimer R; Wernsdorfer W; Kölle EU
    Acta Trop; 1988 Sep; 45(3):217-24. PubMed ID: 2903623
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epidemiology of bullous drug eruptions.
    Breathnach SM; Phillips WG
    Clin Dermatol; 1993; 11(4):441-7. PubMed ID: 8124632
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparative efficacy study of combination fansidar-sulphate quinine and fansidar-HCl tetracycline in falciparum malaria in children above 7 years old.
    Silitonga K; Rampengan TH
    Paediatr Indones; 1991; 31(3-4):111-6. PubMed ID: 1956689
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A case of hypersensitivity type of liver injury induced by pyrimetamine and sulfadoxin (Fansidar)].
    Okazaki Y; Watanabe N; Uchiyama J; Nakano A; Nishizaki Y; Kagawa T; Matsuzaki S
    Nihon Shokakibyo Gakkai Zasshi; 1997 Feb; 94(2):129-32. PubMed ID: 9071177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.